Your SlideShare is downloading. ×
HORMONE REPLACEMENT THERAPY 2
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

HORMONE REPLACEMENT THERAPY 2

1,186
views

Published on


0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,186
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
48
Comments
0
Likes
2
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • One-year treatment with hormone replacement therapy influenced favorably a number of prognostic cardiovascular risk factors in healthy women. The most important effect was the lowering of fibrinogen. Furthermore, in this study the effect of hormone replacement therapy on hemostasis did not deviate between a cyclic estrogen/sequential progestogen regimen and a continuous estrogen/sequential progestogen regimen. (Am J Obstet Gynecol 1999;180:283-9.)
  • Transcript

    • 1. DR FARIHA FAROOQ F.C.P.S CONSULTANT GYNAECOLOGIST FAOOQ HOSPITAL LAHORE-PAKISTAN HORMONE REPLACEMENT THERAPY
    • 2. INDICATIONS
      • MENOPAUSE
      • CLIMECTERIC
      • OSTEOPOROSIS
      • CARDIOVASCULAR
      • PRE MATURE MENOPAUSE
    • 3. MENOPAUSAL SYMPTOMS
      • PHYSICAL
      • PSYCHOLOGICAL
    • 4. PSYCHOLOGICAL SYMPTOMS
      • DEPRESSION
      • IRRITABILITY
      • TIREDNESS / POOR SLEEP
      • ANXIETY
      • LOSS OF LIBIDO
      • WEEPINESS
      • FORGETFULNESS &
      • LOSS OF CONCENTRATION
    • 5. PHYSICAL SYMPTOMS
      • IRREGULAR PERIODS
      • HOT FLUSHES
      • NIGHT SWEATS
      • PALPITATIONS
      • SEXUAL CHANGES
      • SKIN & HAIR
      • JOINT PAINS
      • URINARY SYMPTOMS
      • WEIGHT GAIN
      • HEADACHE
    • 6. LONG TERM MENOPAUSAL EFFECTS
      • ATROPHY OF VAGINA/ URETHRA
      • OSTEOPOROSIS
      • CARDIOVASCULAR DISEASE
    • 7. HORMONES/DRUGS IN HRT
      • NATURAL ESTROGENS
      • PROGESTOGENS
      • TIBOLONE
      • RALOXIFENE( SELECTIVE ESTROGEN RECEPTOR MODULATORS)
    • 8. ROUTS OF T/M
      • ORAL
      • TRANSDERMAL
      • IMPLANTS
      • VAGINAL CREAMS & PESSARIES
    • 9. STRATEGIES OF T/M
    • 10. T/M OF PRE-MENOPAUSAL WOMEN
    • 11. RISKS OF UNOPPOSED ESTROGENS
            • ENDOMETRIAL HYPER PLASIA
            • ADENOCARCINOMA
      • INCREASED RISK OF Ca BREAST
      • 2-4FOLD INCREASED RISK OF
      • DEVELOPING THROMBOLIC DISEASE
    • 12. RISKS OF PROGESTOGENS
      • DEPRESSION
      • WEIGHT GAIN
      • BLOATING
      • ADVERSE AFFECT ON SERUM
      • LIPIDS
    • 13. CONTRAINDICATIONS OF HRT
      • PREVIOUSTHROMBOEMBOLIC DISEASE
      • IMPAIRED LFT/ LIVER DISEASE
      • Ca BREAST
      • Ca ENDOMETRIUM
      • FIBROIDS &ENDOMETRIOSIS(relative) HYPERTENTION,DIABETES,CARDIO-VASCULAR DISEASE ARE NOT C/I